Skip to main content
Top

Reactions Weekly

Issue 1/2022

February 5, 2022

Content (241 Articles)

Glioma Case report

Avapritinib

Cough Case report

AZD-1222

Case report

Belantamab-mafodotin

Cefixime Case report

Cefixime

NSCLC Case report

Durvalumab

Case report

Elasomeran

Migraine Case report

Erenumab

COVID-19 Case report

Heparin

Imatinib Case report

Imatinib

Dementia Case report

Lithium

Melanoma Case report

Nivolumab

Lymphoma Case report

Nivolumab

Melanoma Case report

Nivolumab